Neuroblastoma in adults: Incidence and survival analysis based on SEER data

Pediatric Blood and Cancer

Volumn 49, Issue 1, 2007, Pages 41-46

  Esiashvili, Natia ^a   Goodman, Michael ^b   Ward, Kevin ^b   Marcus Jr , Robert B ^a   Johnstone, Peter A S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Neuroblastoma; SEER; Survival

Indexed keywords

ARTICLE; CANCER INCIDENCE; CHILD; DATA BASE; DISEASE COURSE; EPIDEMIOLOGICAL DATA; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEUROBLASTOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SURVIVAL; SURVIVAL RATE; SURVIVAL TIME;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEUROBLASTOMA; SEER PROGRAM; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34249778983     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20859     Document Type: Article

References (25)

1. Davis S, Rogers M, Pendergrass T. The incidence and epidemiologic characteristics of neuroblastoma in the United States. Am J Epidemiol 1987;6:1063-1074.
2. Castleberry RP. Biology and treatment of neuroblastoma. Pediatr Clin North Am 1997;44:919-937.
3. Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993;11:1466-1477.
4. Katzenstein HM, Bowman LC, Brodeur GM, et al. Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: The pediatric oncology group experience - a pediatric oncology group study. J Clin Oncol 1998;16:2007-2017.
5. Finklestein JZ, Klemperer MR, Evans A, et al. Multiagent chemotherapy for children with metastatic neuroblastoma: A report from the Children's Cancer Study Group. Med Pediatr Oncol 1979;6:179-188.
6. Cohn SL, Moss TJ, Hoover M, et al. Treatment of poor-risk neuroblastoma patients with high-dose chemotherapy and autologous peripheral stem cell rescue. Bone Marrow Transplant 1997;7:543-551.
7. Tang CK, Hajdu SI. Neuroblastoma in adolescence and adulthood. N Y State J Med 1975;75:1434-1438.
8. Dosik GM, Rodriguez V, Benjamin RS, et al. Neuroblastoma in the adult: Effective combination chemotherapy. Cancer 1978;41:56-63.
9. Lopez R, Karakousis C, Rao U. Treatment of adult neuroblastoma. Cancer 1980;45:840-844.
10. Grubb BP, Thant M. Neuroblastoma in an adult. South Med J 1984;77:1180-1182.
11. Aleshire SL, Glick AD, Cruz VE, et al. Neuroblastoma in adults. Pathological findings and clinical outcome. Arch Pathol Lab Med 1985;109:352-356.
12. Kaye JA, Warhol MJ, Kretschmar C, et al. Neuroblastoma in adults. Three case reports and a review of the literature. Cancer 1986; 58:1149-1157.
13. Allan SG, Cornbleet MA, Carmichael J, et al. Adult neuroblastoma. Report of three cases and review of the literature. Cancer 1986;57:2419-2421.
14. Prestidge BR, Donaldson SS. Treatment results among adults with childhood tumors: A 20-year experience. Int J Radiat Oncol Biol Phys 1989;17:507-514.
15. Blatt J, Gula MJ, Orlando SJ, et al. Indolent course of advanced neuroblastoma in children older than 6 years at diagnosis. Cancer 1995;76:890-894.
16. Moody AM, Norma AR, Tait D. Paediatric tumours in the adult population: The experience of the Royal Marsden Hospital 1974-1990. Med Pediatr Oncol 1996;26:153-159.
17. Franks LM, Bollen A, Seeger RC, et al. Neuroblastoma in adults and adolescents. An indolent course with poor survival. Cancer 1997;79:2028-2035.
18. Kushner BH, Kramer K, LaQuaglia MP, et al. Neuroblastoma in adolescents and adults: The Memorial Sloan-Kettering experience. Med Pediatr Oncol 2003;41:508-515.
19. Hankey BF, Ries LA, Edwards BK. The Surveillance, Epidemiology, and End Results Program: A National Resource. Cancer Epidemiol Biomarkers Prev 1999;8:1117-1121.
20. Percy C, Van Holten V, Muir C, et al. International classification of diseases for oncology, 2nd edition. Geneva, Switzerland: World Health Organization; 1992.
21. Hasegawa T, Hirose T, Ayala AG, et al. Adult neuroblastoma of the retroperitoneum and abdomen. Am J Surg Pathol 2001;25:918-924.
22. Matthay KK. Neuroblastoma: Biology and therapy. Oncology 1997;11:1857-1866.
23. Kushner BH, LaQuaglia MP, Bonilla MA, et al. Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age. J Clin Oncol 1994;12:2607-2613.
24. Takita J, Ishii M, Tsutsumi S, et al: Gene expression profiling and identification of novel prognostic marker genes in neuroblastoma. Genes Chromosomes Cancer 2004;40:120-132.
25. Fan J, Tam P, Woude GV, et al. Normalization and analysis of cDNA microarrays using within-array replications applied to neuroblastoma cell response to a cytokine. Proc Natl Acad Sci USA 2004;101:1135-1140.